Page 5 - Hyperfine Inc News Today

Hyperfine (NASDAQ:HYPR – Get Rating) is scheduled to be announcing its earnings results after the market closes on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Hyperfine Stock Down 3.4 […]

Hyperfine (NASDAQ:HYPR – Get Rating) and Cutera (NASDAQ:CUTR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. Insider & Institutional Ownership 27.7% of Hyperfine shares are owned by […]

Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence/Machine Learning Medical Device Market - A Global and Regional Analysis: Focus on...

/PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Artificial...

The market is expected to witness a CAGR of 24.35% during the forecast period 2022-2032. FREMONT, Calif., April 14, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market

Hyperfine (NASDAQ:HYPR – Get Rating) had its price target cut by B. Riley from $3.50 to $2.50 in a research report released on Wednesday, The Fly reports. They currently have a buy rating on the stock. B. Riley also issued estimates for Hyperfine’s Q1 2023 earnings at ($0.16) EPS, Q2 2023 earnings at ($0.16) EPS, […]

Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) – Equities research analysts at B. Riley boosted their FY2023 earnings per share (EPS) estimates for Hyperfine in a research note issued to investors on Tuesday, March 21st. B. Riley analyst N. Chatterji now anticipates that the company will earn ($0.67) per share for the year, up from their […]

Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) device for imaging of the brain, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the company’s upgraded AI-powered software.

Latest Swoop® software improves image quality for DWI imaging of the brain...

New study utilizes Hyperfine, Inc. portable MRI system in monitoring brain injury and evaluating physiological impacts...